| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |